跳至主要内容
临床试验/CTRI/2024/06/069204
CTRI/2024/06/069204尚未招募不适用

: An Etiopathological Study Of Viruddha Ahara And It’s Association To Biomarkers In Shvitra (Vitiligo) - A Case Control Study.

All India Institute Of Ayurveda1 个研究点 分布在 1 个国家目标入组 326 人开始时间: 2024年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
326
试验地点
1
主要终点
To assess the Viruddha Ahara practices in the patients of Shvitra (Vitiligo) and healthy controls.

研究概览

简要总结

Ayurveda uses the term "Viruddha Ahara" to describe unbalanced meal

combinations that can lead to digestive problems, toxic production in the body, and

other health related problems. One of the main causes of Shvitra is Viruddha Aahar

according to Acharya Charakvii. According to numerous research, Vitiligo is an

autoimmune condition. However, the precise causes of this immunological response

in healthy persons remain unknown. But, to the best possible knowledge there is

limited case control study specifically linking role of Viruddha Ahara as an

etiopathological factor in etiopathogenesis of Shvitra (Vitiligo) and in alteration of

biomarker in Shvitra (Vitiligo) patients and healthy controls. As a result, a study

must be conducted to validate the same.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • newly diagnosed cases of shvitra(vitiligo).
  • patient having clinical feature of shvitra(vitiligo).
  • healthy individual fulfilling the criteria of swasthya assessment scale.

排除标准

  • 1.Non-cooperative patients.
  • 2.Pregnant and lactating women.
  • 3.Patients suffering from uncontrolled diabetes and hypertension, any other serious systemic disorders like tuberculosis and malignancy.
  • 4.Patients with history of burn and trauma.
  • 5.Patients suffering from Psychiatric illness.

结局指标

主要结局

To assess the Viruddha Ahara practices in the patients of Shvitra (Vitiligo) and healthy controls.

时间窗: at baseline

次要结局

  • To record the values of AGE and HsCRP in the cases and controls.(To assess the relation between Viruddha Ahara with level of biomarker in patient of Shvitra)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Anjali Chaudhary

All India Institute Of Ayurveda

研究点 (1)

Loading locations...

相似试验